1887

Abstract

There is no large-scale therapy available against human respiratory syncytial virus (hRSV), a major pathogen responsible for acute respiratory diseases. Macaques represent an interesting animal model to evaluate potential treatments because of their genetic, anatomical and immunological proximity with humans. However, the parameters that influence hRSV growth and control in this model are still poorly understood. We have documented in the following study the influence of age as well as repeated infections on the virological, clinical and immunological parameters of this animal model. Following intranasal inoculation, hRSV replicated in the upper respiratory tract for less than 15 days with no clinical signs regardless of age. Interestingly, we observed the induction of a local immune response at the nasal mucosa as assessed by expression profiles of inflammatory and IFN-stimulated genes. Animals also developed specific antibodies and were immune to reinfection. Thus, we showed that even in infant macaques, intranasal hRSV infection induced both local and systemic immune responses to efficiently control the virus.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.000039
2015-04-01
2020-01-21
Loading full text...

Full text loading...

/deliver/fulltext/jgv/96/4/782.html?itemId=/content/journal/jgv/10.1099/vir.0.000039&mimeType=html&fmt=ahah

References

  1. Arai M., Jain S., Weaver A. A., Hill A. A., Guo Y., Bree A. G., Smith M. F. Jr, Allen S. W., LaVallie E. R.. & other authors ( 2010;). Development and application of a biomarker assay for determining the pharmacodynamic activity of an antagonist candidate biotherapeutic antibody to IL21R in whole blood. . J Transl Med 8:, 51. [CrossRef][PubMed]
    [Google Scholar]
  2. Babu P. G., Selvan A., Christuraj S., David J., John T. J., Simoes E. A.. ( 1998;). A primate model of respiratory syncytial virus infection. . Indian J Exp Biol 36:, 758–762.[PubMed]
    [Google Scholar]
  3. Belshe R. B., Richardson L. S., London W. T., Sly D. L., Lorfeld J. H., Camargo E., Prevar D. A., Chanock R. M.. ( 1977;). Experimental respiratory syncytial virus infection of four species of primates. . J Med Virol 1:, 157–162. [CrossRef][PubMed]
    [Google Scholar]
  4. Bem R. A., Domachowske J. B., Rosenberg H. F.. ( 2011;). Animal models of human respiratory syncytial virus disease. . Am J Physiol Lung Cell Mol Physiol 301:, L148–L156. [CrossRef][PubMed]
    [Google Scholar]
  5. Bermejo-Martin J. F., Garcia-Arevalo M. C., De Lejarazu R. O., Ardura J., Eiros J. M., Alonso A., Matías V., Pino M., Bernardo D.. & other authors ( 2007;). Predominance of Th2 cytokines, CXC chemokines and innate immunity mediators at the mucosal level during severe respiratory syncytial virus infection in children. . Eur Cytokine Netw 18:, 162–167.[PubMed]
    [Google Scholar]
  6. Borchers A. T., Chang C., Gershwin M. E., Gershwin L. J.. ( 2013;). Respiratory syncytial virus–a comprehensive review. . Clin Rev Allergy Immunol 45:, 331–379. [CrossRef][PubMed]
    [Google Scholar]
  7. Byrd L. G., Prince G. A.. ( 1997;). Animal models of respiratory syncytial virus infection. . Clin Infect Dis 25:, 1363–1368. [CrossRef][PubMed]
    [Google Scholar]
  8. Choi J., Callaway Z., Kim H. B., Fujisawa T., Kim C. K.. ( 2010;). The role of TNF-alpha in eosinophilic inflammation associated with RSV bronchiolitis. . Pediatr Allergy Immunol 21:, 474–479. [CrossRef][PubMed]
    [Google Scholar]
  9. Collins P. L., Melero J. A.. ( 2011;). Progress in understanding and controlling respiratory syncytial virus: still crazy after all these years. . Virus Res 162:, 80–99. [CrossRef][PubMed]
    [Google Scholar]
  10. Culley F. J., Pennycook A. M., Tregoning J. S., Dodd J. S., Walzl G., Wells T. N., Hussell T., Openshaw P. J.. ( 2006;). Role of CCL5 (RANTES) in viral lung disease. . J Virol 80:, 8151–8157. [CrossRef][PubMed]
    [Google Scholar]
  11. de Swart R. L., Kuiken T., Timmerman H. H., van Amerongen G., van den Hoogen B. G., Vos H. W., Neijens H. J., Andeweg A. C., Osterhaus A. D. M. E.. ( 2002;). Immunization of macaques with formalin-inactivated respiratory syncytial virus (RSV) induces interleukin-13-associated hypersensitivity to subsequent RSV infection. . J Virol 76:, 11561–11569. [CrossRef][PubMed]
    [Google Scholar]
  12. de Waal L., Power U. F., Yüksel S., van Amerongen G., Nguyen T. N., Niesters H. G., de Swart R. L., Osterhaus A. D.. ( 2004a;). Evaluation of BBG2Na in infant macaques: specific immune responses after vaccination and RSV challenge. . Vaccine 22:, 915–922. [CrossRef][PubMed]
    [Google Scholar]
  13. de Waal L., Wyatt L. S., Yüksel S., van Amerongen G., Moss B., Niesters H. G. M., Osterhaus A. D. M. E., de Swart R. L.. ( 2004b;). Vaccination of infant macaques with a recombinant modified vaccinia virus Ankara expressing the respiratory syncytial virus F and G genes does not predispose for immunopathology. . Vaccine 22:, 923–926. [CrossRef][PubMed]
    [Google Scholar]
  14. DeByle C., Bulkow L., Miernyk K., Chikoyak L., Hummel K. B., Hennessy T., Singleton R.. ( 2012;). Comparison of nasopharyngeal flocked swabs and nasopharyngeal wash collection methods for respiratory virus detection in hospitalized children using real-time polymerase chain reaction. . J Virol Methods 185:, 89–93. [CrossRef][PubMed]
    [Google Scholar]
  15. Fjaerli H. O., Bukholm G., Krog A., Skjaeret C., Holden M., Nakstad B.. ( 2006;). Whole blood gene expression in infants with respiratory syncytial virus bronchiolitis. . BMC Infect Dis 6:, 175. [CrossRef][PubMed]
    [Google Scholar]
  16. Grunwald T., Tenbusch M., Schulte R., Raue K., Wolf H., Hannaman D., de Swart R. L., Uberla K., Stahl-Hennig C.. ( 2014;). Novel vaccine regimen elicits strong airway immune responses and control of respiratory syncytial virus in nonhuman primates. . J Virol 88:, 3997–4007. [CrossRef][PubMed]
    [Google Scholar]
  17. Harrison A. M., Bonville C. A., Rosenberg H. F., Domachowske J. B.. ( 1999;). Respiratory syncytical virus-induced chemokine expression in the lower airways: eosinophil recruitment and degranulation. . Am J Respir Crit Care Med 159:, 1918–1924. [CrossRef][PubMed]
    [Google Scholar]
  18. Heikkinen T., Marttila J., Salmi A. A., Ruuskanen O.. ( 2002;). Nasal swab versus nasopharyngeal aspirate for isolation of respiratory viruses. . J Clin Microbiol 40:, 4337–4339. [CrossRef][PubMed]
    [Google Scholar]
  19. Ioannidis I., McNally B., Willette M., Peeples M. E., Chaussabel D., Durbin J. E., Ramilo O., Mejias A., Flaño E.. ( 2012;). Plasticity and virus specificity of the airway epithelial cell immune response during respiratory virus infection. . J Virol 86:, 5422–5436. [CrossRef][PubMed]
    [Google Scholar]
  20. Krilov L. R.. ( 2011;). Respiratory syncytial virus disease: update on treatment and prevention. . Expert Rev Anti Infect Ther 9:, 27–32. [CrossRef][PubMed]
    [Google Scholar]
  21. McArthur-Vaughan K., Gershwin L. J.. ( 2002;). A rhesus monkey model of respiratory syncytial virus infection. . J Med Primatol 31:, 61–73. [CrossRef][PubMed]
    [Google Scholar]
  22. Murai H., Terada A., Mizuno M., Asai M., Hirabayashi Y., Shimizu S., Morishita T., Kakita H., Hussein M. H.. & other authors ( 2007;). IL-10 and RANTES are elevated in nasopharyngeal secretions of children with respiratory syncytial virus infection. . Allergol Int 56:, 157–163. [CrossRef][PubMed]
    [Google Scholar]
  23. Ponnuraj E. M., Hayward A. R., Raj A., Wilson H., Simoes E. A. F.. ( 2001;). Increased replication of respiratory syncytial virus (RSV) in pulmonary infiltrates is associated with enhanced histopathological disease in bonnet monkeys (Macaca radiata) pre-immunized with a formalin-inactivated RSV vaccine. . J Gen Virol 82:, 2663–2674.[PubMed]
    [Google Scholar]
  24. Scagnolari C., Midulla F., Trombetti S., Pierangeli A., Tromba V., Grossi R., Di Marco P., Dianzani C., Girardi E., Antonelli G.. ( 2007;). Upregulation of interferon-induced genes in infants with virus-associated acute bronchiolitis. . Exp Biol Med (Maywood) 232:, 1355–1359. [CrossRef][PubMed]
    [Google Scholar]
  25. Schmidt A. C., Wenzke D. R., McAuliffe J. M., St Claire M., Elkins W. R., Murphy B. R., Collins P. L.. ( 2002;). Mucosal immunization of rhesus monkeys against respiratory syncytial virus subgroups A and B and human parainfluenza virus type 3 by using a live cDNA-derived vaccine based on a host range-attenuated bovine parainfluenza virus type 3 vector backbone. . J Virol 76:, 1089–1099. [CrossRef][PubMed]
    [Google Scholar]
  26. Schmittgen T. D., Livak K. J.. ( 2008;). Analyzing real-time PCR data by the comparative C(T) method. . Nat Protoc 3:, 1101–1108. [CrossRef][PubMed]
    [Google Scholar]
  27. Sheeran P., Jafri H., Carubelli C., Saavedra J., Johnson C., Krisher K., Sánchez P. J., Ramilo O.. ( 1999;). Elevated cytokine concentrations in the nasopharyngeal and tracheal secretions of children with respiratory syncytial virus disease. . Pediatr Infect Dis J 18:, 115–122. [CrossRef][PubMed]
    [Google Scholar]
  28. Simoes E. A. F., Hayward A. R., Ponnuraj E. M., Straumanis J. P., Stenmark K. R., Wilson H. L., Babu P. G.. ( 1999;). Respiratory syncytial virus infects the Bonnet monkey, Macaca radiata. . Pediatr Dev Pathol 2:, 316–326. [CrossRef][PubMed]
    [Google Scholar]
  29. Smith K. G., Clatworthy M. R.. ( 2010;). FcgammaRIIB in autoimmunity and infection: evolutionary and therapeutic implications. . Nat Rev Immunol 10:, 328–343. [CrossRef][PubMed]
    [Google Scholar]
  30. van de Pol A. C., Wolfs T. F., van Loon A. M., Tacke C. E., Viveen M. C., Jansen N. J., Kimpen J. L., Rossen J. W., Coenjaerts F. E.. ( 2010;). Molecular quantification of respiratory syncytial virus in respiratory samples: reliable detection during the initial phase of infection. . J Clin Microbiol 48:, 3569–3574. [CrossRef][PubMed]
    [Google Scholar]
  31. Vaughan K., Rhodes G. H., Gershwin L. J.. ( 2005;). DNA immunization against respiratory syncytial virus (RSV) in infant rhesus monkeys. . Vaccine 23:, 2928–2942. [CrossRef][PubMed]
    [Google Scholar]
  32. Weltzin R., Traina-Dorge V., Soike K., Zhang J.-Y., Mack P., Soman G., Drabik G., Monath T. P.. ( 1996;). Intranasal monoclonal IgA antibody to respiratory syncytial virus protects rhesus monkeys against upper and lower respiratory tract infection. . J Infect Dis 174:, 256–261. [CrossRef][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.000039
Loading
/content/journal/jgv/10.1099/vir.0.000039
Loading

Data & Media loading...

Supplements

Supplementary Data



PDF

Most cited articles

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error